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Abstract
Aim: Patients with endometriosis may suffer from dyslipidemia. Hepatic lipase (HL) is involved in the
metabolism of lipoproteins and has an important role in reverse cholesterol transport. The aim of this study
was to investigate the association between the LIPC-514 C/T polymorphism in the HL gene and the risk of
endometriosis in a group of Iranian women.
Methods: Ninety-seven patients with endometriosis and 107 women who were negative for endometriosis
after diagnostic laparoscopy, as control group, were enrolled in this cross-sectional study. Samples were
analyzed for polymorphism of the HL gene using polymerase chain reaction restriction fragment length
polymorphism.
Results: Multivariate analysis was used to examine the association between the risk of endometriosis and
LIPC-514 C/T polymorphism. There was no statistically significant difference in the frequency of the LIPC-514
C/T polymorphism between patients and the controls (60.7% CC, 34.6% CT, 4.7% TT versus 68.4%, 27.4%,
4.2%, respectively, P = 0.52).
Conclusion: The present study suggested that the LIPC-514 C/T polymorphism of the HL gene has no
significant association with the risk of endometriosis in the studied Iranian women.
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Introduction
Endometriosis is a common chronic gynecologic
disease that is defined as an abnormal placement of
endometrial gland and stroma outside the uterus.1
Abnormal growth of the endometrium is found mainly
on the pelvic and visceral peritoneal surfaces, but also
may be found on the ovaries, rectovaginal, bladder and
bowel.2 Endometriosis is associated with a spectrum of
symptoms of which chronic pelvic pain is the most
common. Dyspareunia, pain during menstruation and
infertility are other symptoms of the disease. Laparos-
copy and biopsy are the primary methods for histo-
logical diagnosis.3,4 Endometriosis is considered a
multifactorial disease and most probably a chronic
inflammation in the peritoneal cavity triggers the dis-
ease.5 Previous studies have shown that oxidative
stress and inflammatory factors are involved in the
pathogenesis and development of endometriosis.6,7 A
similar process exists in cardiovascular disease. There-
fore, an abnormal lipid profile including increased
low-density lipoprotein cholesterol (LDL-C) and
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decreased high-density lipoprotein (HDL-C) and sub-
sequently increased oxidized LDL (oxLDL) particles in
peritoneal fluid could be involved in the development
of endometriosis.8–10 Hepatic lipase (HL) is a lipolytic
enzyme that is synthesized and secreted by the liver.11
It regulates plasma lipids and lipoproteins through the
hydrolysis of triglycerides, LDL particle deformation
and HDL catabolism.11 HL may act as a protein ligand
that facilitates the uptake of lipoproteins by cell surface
receptors.12 The hepatic lipase gene (LIPC) is located in
chromosome 15q21 and is 35 kb in size with nine
exons.13 Several single nucleotide polymorphisms
(SNP) were observed in the 5′-flanking region of the
LIPC (-250G/A, -514C/T, -710T/C)14,15 which has
been associated with HL activity and consistently with
circulating HDL-C levels.16–18 The LIPC-514 C/T poly-
morphism (rs1800588) is a C to T substitution at 514 bp
upstream of the transcription initiation site that is asso-
ciated with low HL activity and higher plasma HDL-C
levels and large LDL particles.19,20 Melo et al.’s study
showed that the abnormal lipid profile with elevated
LDL-C and non-HDL-C may increase oxidative stress
and inflammation in the peritoneal fluid of women and
subsequently the risk of endometriosis.21 Santanam
et al. study suggests that oxLDL particles also can be
involved in the development of endometriosis.8 oxLDL
induces endothelial damage and promotes the migra-
tion of leukocytes and macrophages. The release of
inflammatory cytokines by these cells is followed by a
platelet accumulation and formation of atherosclerotic
plaques.21 Because the LIPC-514 C/T polymorphism
has been associated with dyslipidemia and increased
oxLDL, this polymorphism may also be responsible
for the pathogenesis of endometriosis by inducing a
similar process of inflammation in the peritoneal fluid.
The aim of this study was to find out the frequency of
the LIPC-514 C/T polymorphism and its relationship
with endometriosis risk in Iranian women with
endometriosis.
Methods
Subjects
All subjects (aged 18–42 years) were selected from
women referred to the Kosar Hospital (Qazvin, Iran)
for diagnostic laparoscopy. The study was approved by
the ethics committee of Qazvin University of Medical
Sciences. A total of 97 patients had surgical and histo-
logical evidence of endometriosis, while 107 cases
without the disease served as controls: uterine myoma
(18 cases), dermoid cyst (20 cases), paraovarian cyst (18
cases), serous cyst (15 cases) and healthy women with
infertility and/or pelvic pain (36 cases), as previously
reported by us.22 The extent of the disease was staged
according to the revised American Fertility Society
Classification.23 Among the endometriosis patients, 10
patients were diagnosed with stage I, 13 patients with
stage II, 35 patients with stage III and 39 patients with
stage IV. None of the patients had received hormone
therapy during the previous 12 months. Women were
not included in the study if they had received anti-
inflammatory drugs and contraceptives during the
previous 3 months or if they had urological disease,
endocrine disorders, familial dyslipidemia or chronic
inflammation.
Assay of serum lipids
Before laparoscopy, 5 mL of peripheral fasting blood
samples were obtained and subjected to centrifugation
at 800 g for 5 min. Serum total cholesterol (TC), HDL-C
and triglyceride (TG) were assessed using enzy-
matic methods (Selectra XL, Vitalab, the Netherlands).
LDL-C was calculated using the Friedewald equation.24
All samples were stored at –70°C for later simultaneous
measurement.
Genomic DNA analysis
Genomic DNA was extracted from the leukocytes in
blood samples using a DNA purification kit (Qiagen,
USA). A 285-bp sequence of the LIPC was amplified by
polymerase chain reaction (PCR) in a DNA thermal
cycler (ABI, Veriti, USA) by using oligonucleotide
primers, forward 5′-TCTAGGATCACCTCTCAATGG
GTCA-3′ and reverse 5′-GGTGGCTTCCACGTGG-
CTGCCTAAG-3′.
The PCR condition were 95°C for 3 min, 35 cycles of
95°C for 60 s, 63°C for 30 s, 72°C for 30 s followed by
72°C for 7 min.25 Restriction digestion of the PCR
product with the NlaIII enzyme results in fragments of
215 and 70 bp in rare homozygotes, 285, 215 and 70 bp
in heterozygotes, and 285 bp in common homozygotes.
Statistical analysis
Values were presented as the mean standard devia-
tion, and statistical significance was defined as P < 0.05.
Student’s t-test and c2-test were used to compare vari-
ables between the two groups. Statistically significant
differences in means between genotypes were assessed
by anova. Logistic regression analyses were per-
formed for evaluating genotype distribution with
respect to the presence of endometriosis as a
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dependent variable. All analyses were carried out
using SPSS ver. 11.0 for Windows (SPSS, Chicago, IL,
USA).
Results
Demographic andmetabolic parameters of patients and
controls are shown inTable 1.Womenwith endometrio-
sis had lower body mass index (BMI) values than the
controls (25.1 3.3 vs 26.9 3.9, P = 0.001). The TC
level of the endometriosis group was higher than the
control group (216 38 vs 175  30 mg/dL, P < 0.001)
aswell as the level of LDL-C (130 22 vs 101  20 mg/
dL, P < 0.001) and HDL-C (46 10 vs 40  9 mg/dL,
P < 0.001). TG levels were higher in the endometriosis
group but this difference was not statistically signifi-
cant between the two groups (128 48 mg/dL vs
127  47 mg/dL, P = 0.86). The genotype distribution
of the HL-514 C/T polymorphism of both groups were
in theHardy–Weinberg equilibrium (bothP > 0.05). The
distribution of genotypeswas not different between the
endometriosis group and the control group (68.4% CC,
27.4% CT, 4.2% TT vs 60.7%, 34.6%, 4.7%, respectively,
P = 0.52) (Table 2). The risk of endometriosis in different
genetic groups was calculated by logistic regression
analysis (Table 3). This analysis showed no statistically
significant differences between groups in the risk of
endometriosis (P = 0.24, odds ratio [OR] = 0.64, 95%
confidence interval [CI] = 0.30–1.35), after adjustment
for BMI, HDL-C and LDL-C. In further analyses, we
found also no association between the LIPC-514 C/T
SNP and the four stages of endometriosis. anova
analysis also showed no statistically significant differ-
ences in metabolic parameters in the studied women
(Table 4). Therewasnodifference evenwhen the control
and endometriosis groups were analyzed separately.
Table 1 Metabolic parameters of patients with endometriosis versus control
Control
(n = 107)
Endometriosis
(n = 97)
P
Age, years 29.5  5.5 29.8  5.4 0.66
Body mass index, kg/m2 26.9  3.9 25.1  3.3 0.001
Waist, cm 81.2  9.7 80.6  9.1 0.69
Cholesterol, mg/dL 175  30 216  38 <0.001
Triglyceride, mg/dL 127  47 128  48 0.86
HDL-C, mg/dL 40  9 46  10 <0.001
LDL-C, mg/dL 101  20 130  22 <0.001
Values aremean  standard deviation. HDL-C, high-density lipoprotein cholesterol; LDL-C,
low-density lipoprotein cholesterol.
Table 2 LIPC-514 C/T genotype distributions in patients with endometriosis
versus control
Gene Control
(n = 107)
Endometriosis
(n = 95)
P
CC 65 (60.7%) 65 (68.4%) 0.52
CT 37 (34.6%) 26 (27.4%)
TT 5 (4.7%) 4 (4.2%)
P-values: c2-tests.
Table 3 Logistic regression analysis of LIPC-514 C/T alleles with respect to the
presence of endometriosis as dependent variable
Univariate Multivariate†
OR 95% CI P OR 95% CI P
LIPC-514 T 0.71 0.40–1.28 0.26 0.64 0.30–1.35 0.24
Values are 95% confidence interval (95% CI) and odds ratio (OR). †Adjusted for body mass
index, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol.
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Discussion
The purpose of this study was to test the potential
association of the LIPC-514 C/T polymorphism with
the risk of endometriosis in a population of Iranian
women. Endometriosis is characterized by an inflam-
matory reaction in the peritoneal cavity.5,26 Ploak et al.
study showed an increased oxLDL levels in the perito-
neal fluid of women with advanced stages of
endometriosis.27 High LDL-C levels may be a factor
that stimulates cell proliferation processes in the arte-
rial vessels and can initiate atherosclerosis.9,28 The
present study demonstrated that patients with
endometriosis had lower BMI and higher HDL-C than
the control group. These observations are consistent
with previous studies21,29,30 and have been discussed
earlier.22 In this study, patients with endometriosis had
significantly higher levels of TC and LDL-C than
patients without endometriosis, but no significant dif-
ference was found for TG, which might be attributed to
the lower BMI in the endometriosis group. Previous
studies have reported that BMI is a major contributor
of TG levels.31
Hepatic lipase has a key role in the metabolism of
plasma lipoproteins and is involved in reverse choles-
terol transport.12,32 Human studies have shown that HL
activity tends to be increased in the presence of
smoking, insulin resistance in type II diabetes mellitus
and females with increased omental fat mass, so these
reports suggests that HL may be a proatherogenic
factor.33–35 HL also promotes the formation of small and
dense atherogenic LDL particles.8 The LIPC-514 C/T
polymorphism was first reported to be associated with
the reduced HL activity in men with coronary heart
disease (CHD).18 Several studies have also reported the
relationship between this polymorphism and the risk
of CHD in a different population.36–38 Yamazaki et al.’s
study suggested that in familial combined hyperlipi-
demia, the LIPC-514 T allele led to increase in
malondialdehyde-modified LDL, a species of oxLDL,
which may be a useful biomarker for atherosclerosis.39
Issacs et al.’s study showed that the T allele of the –514
C/T polymorphism in the promoter region of the LIPC
is associated with elevation of HDL-C levels.40 Our
study demonstrated no significant difference in
HDL-C levels in individuals with the TT compared
with the CC genotype, which is inconsistent with some
previous studies.30 HDL-C levels depend on various
factors such as environment, diet, exercise and genet-
ics. In other words, the results of this study indicate
that the T allele alone is not the determinant of plasma
HDL-C levels. Previous findings on the effect of the
LIPC-514 C/T polymorphism on the risk of myocardial
infarction (MI) seems to be inconsistent with our
results. Other studies found either no association41,42 or
a protective effect.43,44 We observed that the genotype
distributions and allele frequency of the LIPC-514
C/T polymorphism were not significantly different
between the individuals with and without endometrio-
sis and between the different stages of endometriosis.
There is ethnic heterogeneity in the LIPC-514 C/T
genotype distribution in healthy populations across the
world. In the present study, the frequency of the LIPC-
514 promoter T allele in females is similar to the fre-
quencies previously reported in Caucasian subjects,
but lower than those in Japanese.45,46
In this study, no significant association between
LIPC-514 C/T genotype and endometriosis was
observed, but due to the small sample size of the popu-
lation examined, further research involving a larger
number of patients is needed. A recent genome-wide
association study conducted on endometriosis identi-
fied few risk loci with OR for the association of less
than 1.5.47 So, consistent with our findings, it is unlikely
Table 4 Metabolic parameter according to genotypes
LIPC-514 C/T
CC CT TT P
n 130 63 9
Age, years 29.9  5.0 29.1  5.3 30.4  6.7 0.56
Body mass index, kg/m2 26.2  4.2 25.7  2.9 26.0  2.8 0.69
Waist, cm 81.0  9.7 80.5  9.1 82.1  8.8 0.87
Cholesterol, mg/dL 196  42 193  37 189  34 0.80
Triglyceride, mg/dL 131  48 123  48 114  39 0.41
HDL-C, mg/dL 43  9 44  12 41  6 0.66
LDL-C, mg/dL 115  28 112  21 114  25 0.73
Values are means  standard deviation, anova. HDL-C, high-density lipoprotein choles-
terol; LDL-C, low-density lipoprotein cholesterol.
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that a hypothetical association between the LIPC-514
C/T SNP and endometriosis would result in an OR of
more than 1.5. The main limitation of the present study
was no standardization of the intensity of patients’
physical activity, a factor that may also influence the
levels of serum lipids. Physical activity level can be
assessed by self-report methods such as questionnaires
and activity diaries.48
To the best of our knowledge, this is the first study to
look for an association between the LIPC-514 C/T
polymorphism of HL and the risk of developing
endometriosis. Our results showed that the LIPC-514
C/T polymorphism is not associated with endometrio-
sis risk in a population of Iranian women. Further
studies are necessary to explain the role of LIPC in the
pathogenesis of endometriosis as well as to character-
ize the relationship of the LIPC-514 C/T polymor-
phism with endometriosis susceptibility.
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